Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
Pfizer
Eli Lilly and Company
Revolution Medicines, Inc.
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Boston Scientific Corporation
Cancer Research UK
Revolution Medicines, Inc.
Eli Lilly and Company
Inhibrx Biosciences, Inc
Cancer Research UK
Cancer Research UK
Cancer Research UK
Elevation Oncology
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Stanford University
Imunon
Kyowa Kirin Co., Ltd.
Taipei Veterans General Hospital, Taiwan
University Hospital, Antwerp
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
The Second Affiliated Hospital of Fujian Medical University
Hoffmann-La Roche
Celgene
Revolution Medicines, Inc.
Jiangxi Provincial Cancer Hospital
Revolution Medicines, Inc.
Zhejiang University
Seoul National University Bundang Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gachon University Gil Medical Center
Isofol Medical AB
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Royal Marsden NHS Foundation Trust
Yale University
Novartis
Merck KGaA, Darmstadt, Germany
University Hospital, Bordeaux
Swedish Medical Center
Assistance Publique - Hôpitaux de Paris
SciClone Pharmaceuticals
Assistance Publique - Hôpitaux de Paris